Fabric Genomics is providing Diagnomics with clinical decision support technology to help healthcare providers understand variants in the ACMG-59 panel.
The companies will integrate Fabric's Enterprise NGS data analysis, interpretation, and clinical reporting platform with Genomenon's literature search engine.
After a 2017 rebranding as Fabric Genomics, the former Omicia is looking to the future of genomics in community hospitals and national sequencing programs.
As of this week, the project had sequenced 39,500 genomes and returned reports for about 3,000 rare disease families and more than 600 cancer patients.
Genome Medical will use the platform for ongoing examination of patients' genomic data to augment data analysis, annotation, and interpretation.
Luxembourg-based data-management firm Information Technology for Translational Medicine will host genomic data for Fabric's customers in the European Union.
The companies aim to offer an end-to-end oncology genomic testing and clinical interpretation service for clinical laboratory customers.
The deal will join Fabric's genome annotation technology with Veritas' myGenome personal whole-genome sequencing service.
The company also announced that it is launching a new end-to-end clinical sequencing platform.
The New York Times Magazine examines gender discrimination at the Salk Institute.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.